Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk (DE:NOV)
XETRA:NOV
Total Valuation
Novo Nordisk has a market cap or net worth of kr307.21B. The enterprise value is €2.14T.
Market Capkr307.21B
Enterprise Value€2.14T
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,390,128,000
Owned by Insiders5.28%
Owned by Institutions<0.01%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 38.99%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.22
Return on Invested Capital (ROIC)38.99%
Return on Capital Employed (ROCE)0.52
Revenue Per Employee3.75M
Profits Per Employee1.30M
Employee Count77,406
Asset Turnover0.62
Inventory Turnover1.09
Valuation Ratios
The current PE Ratio of Novo Nordisk is 27.53. Novo Nordisk’s PEG ratio is 2.14.
PE Ratio27.53
PS Ratio0.00
PB Ratio25.45
Price to Fair Value19.38
Price to FCF33.13
Price to Operating Cash Flow26.94
PEG Ratio2.14
Income Statement
In the last 12 months, Novo Nordisk had revenue of 290.40B and earned 100.99B in profits. Earnings per share was 22.67.
Revenue290.40B
Gross Profit245.88B
Operating Income128.34B
Pretax Income127.19B
Net Income100.99B
EBITDA137.68B
Earnings Per Share (EPS)22.67
Cash Flow
In the last 12 months, operating cash flow was 131.25B and capital expenditures -56.50B, giving a free cash flow of 74.74B billion.
Operating Cash Flow131.25B
Free Cash Flow74.74B
Free Cash Flow per Share22.05
Dividends & Yields
Novo Nordisk pays an annual dividend of €1.059, resulting in a dividend yield of 2.16%
Dividend Per Share€1.059
Dividend Yield2.16%
Payout Ratio33.65%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change-45.96%
50-Day Moving Average59.89
200-Day Moving Average84.43
Relative Strength Index (RSI)70.03
Average Volume (3m)218.13K
Important Dates
Novo Nordisk upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend DateMar 28, 2025
Financial Position
Novo Nordisk as a current ratio of 0.74, with Debt / Equity ratio of 30.88%
Current Ratio0.74
Quick Ratio0.55
Debt to Market Cap0.03
Net Debt to EBITDA0.63
Interest Coverage Ratio66.53
Taxes
In the past 12 months, Novo Nordisk has paid 26.20B in taxes.
Income Tax26.20B
Effective Tax Rate0.21
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 20.83, with an EV/FCF ratio of 41.16.
EV to Sales9.87
EV to EBITDA20.83
EV to Free Cash Flow41.16
EV to Operating Cash Flow23.70
Balance Sheet
Novo Nordisk has kr41.55B in cash and marketable securities with kr118.72B in debt, giving a net cash position of kr77.17B billion.
Cash & Marketable Securitieskr41.55B
Total Debtkr118.72B
Net Cashkr77.17B
Net Cash Per Sharekr22.76
Tangible Book Value Per Sharekr7.27
Margins
Gross margin is 83.92%, with operating margin of 44.19%, and net profit margin of 34.78%.
Gross Margin83.92%
Operating Margin44.19%
Pretax Margin43.80%
Net Profit Margin34.78%
EBITDA Margin47.41%
EBIT Margin44.36%
Analyst Forecast
The average price target for Novo Nordisk is kr88.59, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Targetkr88.59
Price Target Upside27.46% Upside
Analyst ConsensusModerate Buy
Analyst Count13
Revenue Growth Forecast―
EPS Growth Forecast―